What is NeuroAiD™

Why take NeuroAiD™?

2.4 more chances to recover independence

Patients on NeuroAiD™ regain on average 25% of their motor functions

Can result in significant improvements in speech, visual and cognitive functions

What is NeuroAiD?

NeuroAiD™ (MLC 601) is a medicine indicated for post stroke rehabilitation. It is to be taken by stroke patients for faster and better recovery regaining independence as well as from the loss of motor, cognitive and sensory neurological functions.

NeuroAiD™ was historically developed in China as a traditional Chinese medicine to help stroke patients achieve better rehabilitation at late stage. In 2006, NeuroAiD™ was selected as one of the most promising Chinese innovations by the Chinese Ministry of Science and Technology for the Key Technologies Research & Development program.

Moleac, a bio-pharmaceutical company based in Singapore and with offices in France, has identified NeuroAiD™ and its potential to meet the needs of stroke survivors. Moleac is bringing NeuroAiD™ to western medicine internationally and ensures it meets western medicine standards to attend to the needs of stroke sufferers, supporting them to achieve better neurological and functional recovery. After 7 years, NeuroAiD™ is now reaching patients in over 50 countries.

NeuroAiD™ has been welcomed by the media and by clinicians worldwide. Read articles published on NeuroAiD™

Composition & Dosage of NeuroAiD

The NeuroAiD™ stroke treatment capsule is a proprietary blend of ingredients from the Chinese Pharmacopoeia selected from consistent sources and extracted in a standardized proprietary manufacturing process with strict quality and Good Manufacturing Practices (GMP) compliance.

NeuroAiD™ is a natural medicine made of 14 components carefully selected for their efficacy and absence of side effects. Each NeuroAiD™ capsule weighs 0.4 grams and contains extracts from the following main raw materials:

Recommended dosage is four capsules, three times a day for four weeks as one treatment course (10 boxes of 36 capsules each). The first results are usually observed within three to five weeks, and we recommend 3 courses of one-month treatment to achieve best results.

Efficacy and Safety Profile of NeuroAiD

Several studies have been conducted on the efficacy of NeuroAiD™ for patients several months after their stroke and show that patients taking NeuroAiD™ recover better independence.

NeuroAiD™ clinical impact on neurological functions has been documented and is being published.

Our current international trial on 1,100 patients, conducted through the Chinese Medicine Neuroaid Efficacy on Stroke (CHIMES) Society in Asia, to assess the benefits of NeuroAiD™ when given within the first 48 hours and ultimately systematize NeuroAiD™ use as early as possible in the stroke units, is the largest ever trial on a medicine for stroke recovery ever conducted. It is implemented in Asia and has recently been awarded a landmark research grant. Click here to see Clinical Data

NeuroAiD™ safety profile has been validated by several trials which have shown it does not significantly affect hematological, hemostatic, and biochemical parameters nor interacts with aspirin when started and maintained at the early stage of acute stroke. NeuroAiD™ has been available in China for nearly 8 years and no severe adverse reactions were reported. Side effects recorded by Moleac include very rare cases of minor headaches, nausea and increased thirst. Click here to see Safety Data

Purchase of NeuroAiD

Wherever you are in the world, you can order NeuroAiD™ online.

It is shipped from Singapore within one business day and is delivered worldwide within three to five working days.

The NeuroAiD standard treatment (3 months) costs US$ 1346 inclusive of shipping fee.

The NeuroAiD starter treatment (1 month) costs US$ 488 inclusive of shipping fee.